Prurigo
Showing 1 - 25 of 164
Prurigo Nodularis Trial (Dupilumab SAR231893 (REGN668))
Not yet recruiting
- Prurigo Nodularis
- Dupilumab SAR231893 (REGN668)
- (no location specified)
Oct 11, 2023
Prurigo Trial (Ruxolitinib Cream, Vehicle Cream)
Not yet recruiting
- Prurigo
- Ruxolitinib Cream
- Vehicle Cream
- (no location specified)
Feb 23, 2023
Prurigo Nodularis Trial (Ruxolitinib Cream, Vehicle Cream)
Not yet recruiting
- Prurigo Nodularis
- Ruxolitinib Cream
- Vehicle Cream
- (no location specified)
Mar 1, 2023
Disease Activity in Adolescents and Moderate to Severe
Not yet recruiting
- Atopic Dermatitis
- (no location specified)
Jul 7, 2022
Prurigo Nodularis Trial in Germany, United States (CDX-0159, Normal saline)
Recruiting
- Prurigo Nodularis
- CDX-0159
- Normal saline
-
Tempe, Arizona
- +18 more
Jan 4, 2023
Pruritus Trial in Berlin (Aprepitant, Placebo)
Completed
- Pruritus
- Aprepitant
- Placebo
-
Berlin, GermanyAllergie-Zentrum-Charité, Charité - Universitätsmedizin Berlin
Jun 28, 2021
China Type II Inflammatory Skin Disease Clinical Research and
Recruiting
- Atopic Dermatitis Eczema
- Prurigo Nodularis
-
Beijing, ChinaPeking University First Hospital
Mar 29, 2022
Prurigo Nodularis, Pruritis Trial in Worldwide (vixarelimab, Placebo)
Active, not recruiting
- Prurigo Nodularis
- Pruritis
- vixarelimab
- Placebo
-
Anniston, Alabama
- +76 more
Jan 3, 2023
Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis,
Unknown status
- Prurigo Nodularis
- Atopic Dermatitis
- Skin biopsy
- Plastic surgery remnants
- (no location specified)
Feb 6, 2021
Prurigo Nodularis Trial in Germany (serlopitant, Placebo)
Prurigo Nodularis Trial in Worldwide (Nalbuphine ER Tablets, Matching Placebo Tablets)
Active, not recruiting
- Prurigo Nodularis
- Nalbuphine ER Tablets
- Matching Placebo Tablets
-
Phoenix, Arizona
- +69 more
Jan 31, 2023
Prurigo Nodularis, Nodularis Prurigo, Prurigo Trial in Münster (nalbuphine HCl ER)
Completed
- Prurigo Nodularis
- +2 more
- nalbuphine HCl ER
-
Münster, GermanyUniversity of Münster
Oct 5, 2020
Prurigo Nodularis, Nodularis Prurigo, Prurigo Trial in Germany, Poland, United States (nalbuphine HCl ER tablets 90 mg BID,
Completed
- Prurigo Nodularis
- +3 more
- nalbuphine HCl ER tablets 90 mg BID
- +2 more
-
Cleveland, Ohio
- +3 more
Oct 5, 2020
Pruritus, Prurigo Nodularis Trial in Austria, Germany, Poland (5mg Serlopitant Tablets, Placebo Tablets)
Completed
- Pruritus
- Prurigo Nodularis
- 5mg Serlopitant Tablets
- Placebo Tablets
-
Graz, Austria
- +39 more
May 18, 2021
Neurodermatitis Trial in Worldwide (Dupilumab SAR231893, Placebo, Moisturizers)
Completed
- Neurodermatitis
- Dupilumab SAR231893
- +4 more
-
Gilbert, Arizona
- +62 more
Nov 11, 2022
Prurigo Nodularis Trial in Worldwide (Nemolizumab 30 mg, Placebo)
Recruiting
- Prurigo Nodularis
- Nemolizumab 30 mg
- Placebo
-
Birmingham, Alabama
- +109 more
Jun 29, 2022
Keloid, Alopecia Areata, Acne Trial in Nashville (Corticosteroid with lidocaine, Corticosteroid with normal saline)
Completed
- Keloid
- +14 more
- Corticosteroid with lidocaine
- Corticosteroid with normal saline
-
Nashville, TennesseeVanderbilt University Medical Center
Feb 18, 2021
Pruritus, Prurigo Nodularis Trial in United States (5mg Serlopitant Tablets, Placebo Tablets)
Completed
- Pruritus
- Prurigo Nodularis
- 5mg Serlopitant Tablets
- Placebo Tablets
-
Birmingham, Alabama
- +48 more
May 18, 2021
Neurodermatitis Trial in Worldwide (Dupilumab SAR231893, Placebo, Moisturizers)
Completed
- Neurodermatitis
- Dupilumab SAR231893
- +4 more
-
Fort Smith, Arkansas
- +56 more
Dec 2, 2021
Prurigo Nodularis Trial in Worldwide (CD14152 Dose A, CD14152 )
Completed
- Prurigo Nodularis
- CD14152 Dose A
- CD14152 placebo
-
Graz, Austria
- +15 more
Feb 7, 2020
Pruritus, Prurigo Nodularis, Atopic Dermatitis Trial in Worldwide (5 mg Serlopitant Tablets)
Terminated
- Pruritus
- +3 more
- 5 mg Serlopitant Tablets
-
Birmingham, Alabama
- +84 more
May 18, 2021
Pruritus Trial in Basel (Data collection)
Recruiting
- Pruritus
- Data collection
-
Basel, SwitzerlandDepartment of Dermatology, University Hospital Basel
Nov 8, 2023